marketcaparena
Search

    RGNX

    REGENXBIO Inc.

    Company overview

    Market capitalization
    $493.12M
    Employees
    371
    Latest publication
    2026-09-29
    About REGENXBIO Inc.

    REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202 for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 and with Nippon Shinyaku Co., Ltd. to develop RGX-121 and RGX-111 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20252025-03-31 · USDQ4 20212021-12-31 · USDQ3 20202020-09-30 · USDQ1 20192019-03-31 · USDQ4 20182018-12-31 · USDQ3 20182018-09-30 · USDQ2 20182018-06-30 · USD
    Total Revenue108,019,000USD89,012,000USD398,655,000USD98,912,000USD884,000USD40,777,000USD5,306,000USD40,031,000USD
    Cost Of Revenue1,054,000USD3,436,000USD23,058,000USD17,364,000USD29,000USD2,843,000USD517,000USD3,872,000USD
    Gross Profit106,965,000USD85,576,000USD375,597,000USD81,548,000USD855,000USD37,934,000USD4,789,000USD36,159,000USD
    Research Development56,086,000USD53,087,000USD47,978,000USD43,968,000USD25,203,000USD24,329,000USD18,508,000USD21,486,000USD
    General And Administrative Expenses21,616,000USD———————
    Total Operating Expenses77,702,000USD73,449,000USD62,001,000USD67,597,000USD36,761,000USD35,484,000USD27,514,000USD29,809,000USD
    Operating Income29,263,000USD12,127,000USD313,596,000USD13,951,000USD-35,906,000USD2,450,000USD-22,725,000USD6,350,000USD
    Total Other Income Expense Net-6,554,000USD-6,044,000USD-6,170,000USD-5,163,000USD3,608,000USD3,477,000USD2,231,000USD8,094,000USD
    Interest Expense7,793,000USD8,570,000USD6,500,000USD——0USD0USD0USD
    Net Income22,709,000USD6,083,000USD294,023,000USD8,791,000USD-32,228,000USD4,306,000USD-19,202,000USD10,594,000USD
    Selling General Administrative—20,347,000USD22,040,000USD15,859,000USD11,558,000USD11,144,000USD9,008,000USD8,318,000USD
    Interest Income—25,000USD19,000USD1,444,000USD3,608,000USD———
    Net Interest Income—-8,545,000USD-6,481,000USD1,444,000USD613,000USD———
    Income Before Tax—6,083,000USD307,426,000USD8,788,000USD-32,298,000USD5,927,000USD-20,494,000USD14,444,000USD
    Net Income From Continuing Ops—6,083,000USD294,023,000USD8,791,000USD-32,228,000USD4,306,000USD-19,202,000USD10,594,000USD
    Ebit—14,653,000USD313,926,000USD8,788,000USD-35,906,000USD2,450,000USD-22,725,000USD6,350,000USD
    Ebitda—18,608,000USD316,532,000USD10,964,000USD-34,292,000USD3,761,000USD-21,784,000USD7,246,000USD
    Depreciation And Amortization—3,955,000USD2,606,000USD2,176,000USD1,614,000USD1,311,000USD941,000USD896,000USD
    Reconciled Depreciation—3,955,000USD2,606,000USD2,176,000USD1,614,000USD1,311,000USD941,000USD896,000USD
    Unclassified Operating Expenses——-8,017,000USD7,770,000USD————
    Income Tax Expense——13,403,000USD-3,000USD-70,000USD1,621,000USD-1,292,000USD3,850,000USD
    Tax Provision——13,403,000USD-3,000USD-70,000USD———
    Non Operating Income Net Other——330,000USD-5,163,000USD3,608,000USD—2,231,000USD8,094,000USD
    Net Income Applicable To Common Shares——294,023,000USD8,791,000USD-32,228,000USD4,306,000USD-19,202,000USD10,594,000USD
    Minority Interest—————0USD0USD0USD
    Discontinued Operations—————0USD0USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20212021-12-31 · USDFY 20182018-12-31 · USDFY 20162016-12-31 · USDFY 20132013-12-31 · USD
    Total Revenue470,347,000USD218,505,000USD4,589,000USD6,087,000USD
    Cost Of Revenue51,833,000USD9,640,000USD959,000USD324,000USD
    Gross Profit418,514,000USD208,865,000USD3,630,000USD5,763,000USD
    Research Development181,437,000USD83,873,000USD45,482,000USD5,051,000USD
    Selling General Administrative79,333,000USD36,850,000USD23,590,000USD5,474,000USD
    Total Operating Expenses258,534,000USD120,765,000USD68,970,000USD10,525,000USD
    Operating Income159,980,000USD88,100,000USD-65,340,000USD-4,776,000USD
    Interest Income719,000USD8,946,000USD1,938,000USD—
    Interest Expense26,277,000USD0USD0USD611,000USD
    Net Interest Income-25,558,000USD8,946,000USD0USD—
    Income Before Tax141,247,000USD104,116,000USD-63,402,000USD-5,387,000USD
    Income Tax Expense13,407,000USD4,179,000USD-435,000USD597,000USD
    Tax Provision13,407,000USD4,179,000USD-435,000USD—
    Net Income127,840,000USD99,937,000USD-62,967,000USD-5,387,000USD
    Net Income From Continuing Ops127,840,000USD99,937,000USD-62,967,000USD—
    Ebit167,524,000USD88,100,000USD-65,340,000USD-4,790,000USD
    Ebitda177,088,000USD92,082,000USD-64,796,000USD-4,776,000USD
    Depreciation And Amortization9,564,000USD3,982,000USD544,000USD14,000USD
    Reconciled Depreciation9,564,000USD3,982,000USD——
    Total Other Income Expense Net-18,733,000USD16,016,000USD1,938,000USD-611,000USD
    Non Operating Income Net Other7,544,000USD16,016,000USD1,938,000USD—
    Net Income Applicable To Common Shares127,840,000USD99,937,000USD-62,967,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets386,618,000USD341,894,000USD453,032,000USD525,203,000USD581,027,000USD490,929,000USD465,989,000USD519,114,000USD
    Cash And Equivalents36,487,000USD———————
    Cash And Short Term Investments105,517,000USD150,491,000USD230,070,000USD274,205,000USD323,298,000USD267,869,000USD234,687,000USD255,460,000USD
    Short Term Investments69,030,000USD135,262,000USD195,604,000USD215,403,000USD243,740,000USD137,765,000USD177,161,000USD198,843,000USD
    Total Current Assets236,157,000USD186,516,000USD281,281,000USD331,967,000USD373,752,000USD313,237,000USD278,001,000USD313,396,000USD
    Other Current Assets11,757,000USD25,085,000USD23,828,000USD31,295,000USD28,968,000USD26,211,000USD21,747,000USD32,754,000USD
    Other Non Current Assets5,902,000USD———————
    Total Liabilities314,853,000USD———————
    Total Current Liabilities82,621,000USD71,110,000USD118,095,000USD124,568,000USD119,540,000USD106,731,000USD103,194,000USD102,725,000USD
    Other Non Current Liabilities486,000USD———————
    Total Stockholder Equity71,765,000USD21,082,000USD102,733,000USD161,452,000USD213,679,000USD274,197,000USD259,651,000USD301,416,000USD
    Total Equity Including Noncontrolling Interest71,765,000USD———————
    Deferred Revenue9,882,000USD———————
    Deferred Revenue Non Current15,404,000USD———————
    Net Receivables106,754,000USD10,940,000USD27,383,000USD26,467,000USD21,486,000USD19,157,000USD21,567,000USD25,182,000USD
    Property Plant Equipment Net142,319,000USD147,415,000USD152,011,000USD156,335,000USD161,486,000USD166,609,000USD171,305,000USD175,844,000USD
    Accounts Payable15,546,000USD21,207,000USD21,358,000USD22,266,000USD21,655,000USD19,044,000USD22,798,000USD19,522,000USD
    Short Term Debt7,355,000USD7,867,000USD47,895,000USD50,791,000USD8,049,000USD7,942,000USD7,902,000USD7,720,000USD
    Common Stock5,000USD5,000USD5,000USD5,000USD5,000USD5,000USD5,000USD5,000USD
    Retained Earnings-1,193,369,000USD-1,216,078,000USD-1,126,027,000USD-1,058,877,999USD-996,937,000USD-926,066,000USD-932,149,000USD-880,963,000USD
    Accumulated Other Comprehensive Income-875,000USD-870,000USD-687,000USD-652,000USD-750,000USD-762,000USD-741,000USD-582,000USD
    Total Liab—320,812,000USD350,299,000USD363,751,000USD367,348,000USD216,732,000USD206,338,000USD217,698,000USD
    Other Current Liab—36,117,000USD38,390,000USD38,316,000USD75,859,000USD66,157,000USD72,379,000USD75,339,000USD
    Capital Stock—5,000USD5,000USD5,000USD5,000USD5,000USD5,000USD5,000USD
    Cash—15,229,000USD34,466,000USD58,802,000USD79,558,000USD130,104,000USD57,526,000USD56,617,000USD
    Current Deferred Revenue—5,919,000USD10,452,000USD13,195,000USD13,977,000USD13,588,000USD115,000USD144,000USD
    Net Debt—55,837,000USD226,052,000USD209,338,000USD-1,862,000USD-50,256,000USD24,507,000USD27,445,000USD
    Short Long Term Debt Total—71,066,000USD260,518,000USD268,140,000USD77,696,000USD79,848,000USD82,033,000USD84,062,000USD
    Long Term Investments—0USD10,785,000USD27,838,000USD40,296,000USD4,858,000USD10,179,000USD23,108,000USD
    Property Plant Equipment Gross—238,420,000USD239,203,000USD239,874,000USD241,542,000USD242,778,000USD243,597,000USD245,193,000USD
    Common Stock Shares Outstanding—52,428,000shares51,752,000shares51,689,000shares51,483,000shares51,434,000shares50,871,000shares50,800,000shares
    Non Current Assets Total—155,378,000USD171,751,000USD193,236,000USD207,275,000USD177,692,000USD187,988,000USD205,718,000USD
    Non Current Liabilities Total—249,702,000USD232,204,000USD239,183,000USD247,808,000USD110,001,000USD103,144,000USD114,973,000USD
    Non Current Liabilities Other—163,727,000USD148,046,000USD150,564,000USD154,357,000USD11,798,000USD29,013,000USD38,631,000USD
    Non Currrent Assets Other—5,513,000USD4,613,000USD4,267,999USD5,493,000USD6,225,000USD6,504,000USD6,766,000USD
    Net Working Capital—115,406,000USD163,186,000USD207,399,000USD254,212,000USD206,506,000USD174,807,000USD210,671,000USD
    Unclassified Non Current Assets—2,450,000USD4,342,000USD4,795,001USD————
    Unclassified Non Current Liabilities—85,975,000USD84,158,000USD88,619,000USD93,451,000USD98,203,000USD74,131,000USD76,342,000USD
    Unclassified Equity—1,238,020,000USD1,229,437,000USD1,220,971,999USD1,211,356,000USD1,201,015,000USD1,192,531,000USD1,182,951,000USD
    Inventory———————-12,580,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets453,032,000USD465,989,000USD573,970,000USD833,268,000USD1,113,904,000USD708,164,000USD497,908,000USD543,814,000USD
    Other Current Assets23,828,000USD21,747,000USD33,372,000USD21,042,000USD28,948,000USD1,953,000USD10,674,000USD9,565,000USD
    Total Liab350,299,000USD206,338,000USD262,228,000USD317,073,000USD349,606,000USD330,411,000USD47,711,000USD34,966,000USD
    Total Stockholder Equity102,733,000USD259,651,000USD311,742,000USD516,195,000USD764,298,000USD377,753,000USD450,197,000USD508,848,000USD
    Other Current Liab38,390,000USD72,379,000USD100,270,000USD95,395,000USD102,675,000USD64,741,000USD24,846,000USD16,438,000USD
    Common Stock5,000USD5,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD
    Capital Stock5,000USD5,000USD4,000USD4,000USD4,000USD4,000USD4,000USD4,000USD
    Retained Earnings-1,126,027,000USD-932,149,000USD-705,047,000USD-441,553,000USD-161,232,000USD-289,072,000USD-177,822,000USD-83,016,000USD
    Cash34,466,000USD57,526,000USD34,522,000USD96,952,000USD345,209,000USD338,426,000USD69,514,000USD75,561,000USD
    Cash And Short Term Investments230,070,000USD234,687,000USD275,258,000USD364,642,000USD457,439,000USD475,740,000USD296,210,000USD319,761,000USD
    Total Current Assets281,281,000USD278,001,000USD334,971,000USD415,976,000USD518,826,000USD531,197,000USD345,032,000USD337,913,000USD
    Total Current Liabilities118,095,000USD103,194,000USD130,272,000USD130,434,000USD130,472,000USD81,447,000USD33,676,000USD22,176,000USD
    Current Deferred Revenue10,452,000USD115,000USD148,000USD1,829,000USD3,333,000USD449,000USD3,333,000USD600,000USD
    Net Debt226,052,000USD24,507,000USD54,768,000USD-2,153,000USD-258,528,000USD-265,773,000USD-58,219,000USD-69,707,000USD
    Short Term Debt47,895,000USD7,902,000USD7,068,000USD5,997,000USD1,752,000USD2,500,000USD2,421,000USD—
    Short Long Term Debt Total260,518,000USD82,033,000USD89,290,000USD94,799,000USD86,681,000USD72,653,000USD11,295,000USD5,854,000USD
    Long Term Investments10,785,000USD10,179,000USD38,871,000USD200,560,000USD394,169,000USD50,076,000USD103,785,000USD150,819,000USD
    Short Term Investments195,604,000USD177,161,000USD240,736,000USD267,690,000USD112,230,000USD137,314,000USD226,696,000USD244,200,000USD
    Net Receivables27,383,000USD21,567,000USD26,341,000USD30,292,000USD32,439,000USD42,999,000USD38,148,000USD8,587,000USD
    Accounts Payable21,358,000USD22,798,000USD22,786,000USD27,213,000USD11,387,000USD10,622,000USD6,409,000USD4,412,000USD
    Property Plant Equipment Net152,011,000USD171,305,000USD192,590,000USD206,801,000USD192,451,000USD120,282,000USD39,051,000USD28,702,000USD
    Property Plant Equipment Gross239,203,000USD243,597,000USD249,798,000USD206,801,000USD192,451,000USD120,282,000USD39,051,000USD28,702,000USD
    Accumulated Other Comprehensive Income-687,000USD-741,000USD-4,429,000USD-15,401,000USD-2,569,000USD-360,000USD205,000USD-720,000USD
    Common Stock Shares Outstanding51,573,000shares49,509,000shares43,734,000shares43,152,000shares43,913,000shares37,281,000shares36,690,000shares36,648,000shares
    Non Current Assets Total171,751,000USD187,988,000USD238,999,000USD417,292,000USD595,078,000USD176,967,000USD152,876,000USD205,901,000USD
    Non Current Liabilities Total232,204,000USD103,144,000USD131,956,000USD186,639,000USD219,134,000USD248,964,000USD14,035,000USD12,790,000USD
    Non Current Liabilities Other148,046,000USD29,013,000USD49,734,000USD97,837,000USD219,134,000USD248,964,000USD1,828,000USD2,505,000USD
    Non Currrent Assets Other4,613,000USD6,504,000USD7,538,000USD9,931,000USD10,720,000USD9,876,000USD10,040,000USD26,380,000USD
    Net Working Capital163,186,000USD174,807,000USD204,699,000USD285,542,000USD388,354,000USD449,750,000USD311,356,000USD315,737,000USD
    Unclassified Non Current Assets4,342,000USD——-9,931,000USD-1,116,166,000USD-12,043,000USD-10,040,000USD-25,980,000USD
    Unclassified Non Current Liabilities84,158,000USD74,131,000USD82,222,000USD-9,035,000USD-134,205,000USD-178,811,000USD7,046,000USD2,251,000USD
    Unclassified Equity1,229,437,000USD1,192,531,000USD1,021,210,000USD973,141,000USD928,091,000USD667,177,000USD627,806,000USD592,576,000USD
    Other Liab———97,837,000USD134,205,000USD178,811,000USD5,161,000USD6,936,000USD
    Other Assets———9,931,000USD1,113,904,000USD8,776,000USD10,040,000USD25,980,000USD
    Inventory———13,900,000USD18,752,000USD10,505,000USD6,475,000USD5,734,000USD
    Net Tangible Assets———516,195,000USD764,298,000USD377,753,000USD450,197,000USD508,848,000USD
    Unclassified Current Assets———-13,900,000USD-18,752,000USD—-6,475,000USD-5,734,000USD
    Unclassified Current Liabilities————11,325,000USD3,135,000USD-3,333,000USD—
    Deferred Long Term Liab———————1,098,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-90,051,000USD-67,149,000USD-61,941,000USD-70,871,000USD6,083,000USD-51,186,000USD-59,597,000USD-52,989,000USD
    Depreciation3,857,000USD3,869,000USD3,886,000USD3,905,000USD3,955,000USD4,023,000USD3,961,000USD4,051,000USD
    Stock Based Compensation8,617,000USD8,375,000USD8,998,000USD8,653,000USD8,537,000USD9,542,000USD9,884,000USD9,435,000USD
    Other Non Cash Items2,893,000USD4,414,000USD3,468,000USD1,433,000USD-1,358,000USD-5,660,000USD-866,000USD-1,958,000USD
    Change To Account Receivables18,249,000USD-561,000USD-6,310,000USD-2,362,000USD1,572,000USD8,133,000USD-710,000USD-6,893,000USD
    Change In Working Capital-1,502,000USD-1,799,000USD-10,371,000USD7,538,000USD16,412,000USD11,657,000USD6,069,000USD-4,036,000USD
    Total Cash From Operating Activities-76,186,000USD-52,290,000USD-55,960,000USD-49,342,000USD33,629,000USD-31,624,000USD-40,549,000USD-45,497,000USD
    Capital Expenditures-1,235,000USD-508,000USD-491,000USD-391,000USD-1,024,000USD-1,079,000USD-326,000USD-474,000USD
    Free Cash Flow-77,421,000USD-52,798,000USD-56,451,000USD-49,733,000USD32,605,000USD-32,703,000USD-40,875,000USD-45,971,000USD
    Investments71,823,000USD38,046,000USD42,287,000USD-140,436,000USD44,743,000USD40,273,000USD50,258,000USD-268,000USD
    Total Cashflows From Investing Activities70,588,000USD37,538,000USD42,287,000USD-140,436,000USD44,743,000USD40,273,000USD50,258,000USD-268,000USD
    Total Cash From Financing Activities-13,639,000USD-9,584,000USD-7,083,000USD139,232,000USD-5,794,000USD-7,740,000USD-10,857,000USD-9,445,000USD
    Issuance Of Capital Stock648,000USD0USD741,000USD0USD307,000USD0USD246,000USD-249,000USD
    Change In Cash-19,237,000USD-24,336,000USD-20,756,000USD-50,546,000USD72,578,000USD909,000USD-1,148,000USD-55,210,000USD
    Begin Period Cash Flow34,466,000USD60,832,000USD79,558,000USD132,134,000USD59,556,000USD58,647,000USD59,795,000USD115,005,000USD
    End Period Cash Flow15,229,000USD36,496,000USD58,802,000USD81,588,000USD132,134,000USD59,556,000USD58,647,000USD59,795,000USD
    Other Cashflows From Financing Activities-14,203,000USD134,842,000USD-7,716,000USD-5,260,000USD-6,101,000USD-7,778,000USD-11,352,000USD-9,196,000USD
    Net Borrowings—0USD-33,000USD—————
    Unclassified Financing Cash Flow—-144,426,000USD—144,492,000USD————
    Sale Purchase Of Stock——741,000USD—307,000USD—780,000USD—
    Other Cashflows From Investing Activities——62,000USD————206,000USD
    Unclassified Investing Cash Flow————1,024,000USD1,079,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-193,878,000USD-227,102,000USD-263,494,000USD-280,321,000USD127,840,000USD-111,250,000USD-94,733,000USD99,937,000USD
    Depreciation15,615,000USD16,215,000USD17,320,000USD12,909,000USD9,564,000USD8,407,000USD7,152,000USD3,982,000USD
    Stock Based Compensation34,563,000USD38,463,000USD40,267,000USD40,788,000USD38,808,000USD31,949,000USD26,854,000USD16,641,000USD
    Other Non Cash Items7,957,000USD-6,234,000USD-1,613,000USD5,159,000USD4,361,000USD-1,229,000USD-2,683,000USD-8,932,000USD
    Change To Account Receivables-7,661,000USD9,707,000USD3,935,000USD4,822,000USD14,118,000USD-9,898,000USD-8,622,000USD-16,803,000USD
    Change In Working Capital11,780,000USD5,533,000USD-10,887,000USD13,977,000USD40,218,000USD14,219,000USD-5,325,000USD-7,774,000USD
    Total Cash From Operating Activities-123,963,000USD-173,125,000USD-218,407,000USD-207,488,000USD218,875,000USD-54,061,000USD-107,705,000USD104,648,000USD
    Capital Expenditures-2,414,000USD-2,436,000USD-9,960,000USD-30,724,000USD-84,175,000USD-26,869,000USD-11,720,000USD-13,278,000USD
    Free Cash Flow-126,377,000USD-175,561,000USD-228,367,000USD-238,212,000USD134,700,000USD-80,930,000USD-119,425,000USD91,370,000USD
    Investments-13,454,000USD103,446,000USD183,669,000USD-11,929,000USD-322,467,000USD147,341,000USD105,279,000USD-266,080,000USD
    Total Cashflows From Investing Activities-15,868,000USD103,446,000USD190,943,000USD-11,929,000USD-406,642,000USD122,759,000USD93,559,000USD-279,358,000USD
    Net Borrowings144,493,000USD0USD——————
    Total Cash From Financing Activities116,771,000USD92,683,000USD-34,966,000USD-28,840,000USD195,250,000USD200,214,000USD8,376,000USD204,443,000USD
    Sale Purchase Of Stock1,048,000USD1,191,000USD-419,000USD-284,000USD-2,000USD1,799,000USD1,314,000USD847,000USD
    Issuance Of Capital Stock1,048,000USD132,258,000USD6,700,000USD1,742,000USD216,438,000USD1,799,000USD1,556,000USD189,716,000USD
    Change In Cash-23,060,000USD23,004,000USD-62,430,000USD-248,257,000USD7,483,000USD268,912,000USD-5,770,000USD29,733,000USD
    Begin Period Cash Flow59,556,000USD36,552,000USD98,982,000USD347,239,000USD339,756,000USD70,844,000USD76,614,000USD46,881,000USD
    End Period Cash Flow36,496,000USD59,556,000USD36,552,000USD98,982,000USD347,239,000USD339,756,000USD70,844,000USD76,614,000USD
    Other Cashflows From Investing Activities62,000USD5,783,000USD—0USD4,991,000USD149,628,000USD295,984,000USD179,710,000USD
    Other Cashflows From Financing Activities115,762,000USD-39,575,000USD-41,666,000USD-30,582,000USD-22,956,000USD198,415,000USD7,062,000USD13,880,000USD
    Unclassified Financing Cash Flow-144,532,000USD131,067,000USD7,119,000USD2,026,000USD218,208,000USD——189,716,000USD
    Unclassified Investing Cash Flow—-3,347,000USD17,234,000USD30,724,000USD-4,991,000USD-147,341,000USD-295,984,000USD-179,710,000USD
    Change To Liabilities———17,625,000USD-3,203,000USD20,049,000USD7,287,000USD9,050,000USD
    Change To Inventory————29,303,000USD17,850,000USD2,369,000USD5,346,000USD
    Cash And Cash Equivalents Changes————7,483,000USD268,912,000USD-5,770,000USD29,733,000USD
    Unclassified Operating Cash Flow—————3,843,000USD-38,970,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductLicense And Service103,841,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductServices4,178,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductLicense And Service5,090,000USD0001193125-26-222804
    Q1 2026Quarterly · 2026-03-31ProductServices1,303,000USD0001193125-26-222804
    Q4 2025Quarterly · 2025-12-31ProductLicense And Service27,148,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductServices3,189,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductLicense And Service156,267,000USD0001193125-26-094013
    FY 2025Yearly · 2025-12-31ProductServices14,174,000USD0001193125-26-094013
    Q3 2025Quarterly · 2025-09-30ProductLicense And Service23,605,000USD0001193125-25-268095
    Q3 2025Quarterly · 2025-09-30ProductServices6,128,000USD0001193125-25-268095
    Q2 2025Quarterly · 2025-06-30ProductLicense And Service18,465,000USD0001193125-25-174953
    Q2 2025Quarterly · 2025-06-30ProductServices2,894,000USD0001193125-25-174953
    Q1 2025Quarterly · 2025-03-31ProductLicense And Service87,049,000USD0001193125-26-222804
    Q1 2025Quarterly · 2025-03-31ProductServices1,963,000USD0001193125-26-222804
    Q4 2024Quarterly · 2024-12-31ProductLicense And Service20,788,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductServices426,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductLicense And Service81,960,000USD0001193125-26-094013
    FY 2024Yearly · 2024-12-31ProductServices1,368,000USD0001193125-26-094013
    Q3 2024Quarterly · 2024-09-30ProductLicense And Service23,982,000USD0001193125-25-268095
    Q3 2024Quarterly · 2024-09-30ProductServices215,000USD0001193125-25-268095
    FY 2021Yearly · 2021-12-31ProductAbb Vie Collaboration And License Agreement370,000,000USD0000950170-24-021161
    FY 2021Yearly · 2021-12-31ProductOther5,369,000USD0000950170-24-021161
    FY 2021Yearly · 2021-12-31ProductZolgensma Royalties94,978,000USD0000950170-24-021161
    FY 2020Yearly · 2020-12-31ProductAchievement Of Sales Based Milestone For Zolgensma80,000,000USD0000950170-23-005085
    FY 2020Yearly · 2020-12-31ProductOther3,500,000USD0000950170-23-005085
    FY 2020Yearly · 2020-12-31ProductZolgensma Royalties61,631,000USD0000950170-23-005085
    FY 2019Yearly · 2019-12-31ProductLicense3,500,000USD0001564590-21-009855
    FY 2019Yearly · 2019-12-31ProductZolgensma Royalties20,829,000USD0001564590-21-009855
    FY 2018Yearly · 2018-12-31ProductLicense0USD0001564590-20-006826
    FY 2018Yearly · 2018-12-31ProductLicense And Service218,505,000USD0001564590-20-006826
    FY 2017Yearly · 2017-12-31ProductLicense10,385,000USD0001564590-19-004920
    FY 2017Yearly · 2017-12-31ProductProduct And Service Other8,000USD0001564590-19-004920
    FY 2016Yearly · 2016-12-31ProductLicense4,303,000USD0001564590-19-004920
    FY 2016Yearly · 2016-12-31ProductProduct And Service Other286,000USD0001564590-19-004920

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.